These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1634646)

  • 1. Multiple dose pharmacokinetics of four different doses of nisoldipine in hypertensive patients.
    Chandler MH; Clifton GD; Lettieri JT; Mazzu AL; Allington DR; Thieneman AC; Foster TS; Harrison MR
    J Clin Pharmacol; 1992 Jun; 32(6):571-5. PubMed ID: 1634646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of nisoldipine coat-core.
    Heinig R
    Clin Pharmacokinet; 1998 Sep; 35(3):191-208. PubMed ID: 9784933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus.
    Marques MP; Coelho EB; Dos Santos NA; Geleilete TJ; Lanchote VL
    Eur J Clin Pharmacol; 2002 Dec; 58(9):607-14. PubMed ID: 12483453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form.
    Schaefer HG; Heinig R; Ahr G; Adelmann H; Tetzloff W; Kuhlmann J
    Eur J Clin Pharmacol; 1997; 51(6):473-80. PubMed ID: 9112062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced plasma nisoldipine concentrations in phenytoin-treated patients with epilepsy.
    Michelucci R; Cipolla G; Passarelli D; Gatti G; Ochan M; Heinig R; Tassinari CA; Perucca E
    Epilepsia; 1996 Nov; 37(11):1107-10. PubMed ID: 8917062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of nisoldipine in hypertensive patients with normal and mild to moderate impaired renal function.
    Shionoiri H; Minamisawa K; Masumori S; Satta H; Minamisawa M; Takizawa T; Jinno Y; Takeda K; Nagasawa T; Takasaki I
    Arzneimittelforschung; 1995 Jul; 45(7):785-9. PubMed ID: 8573223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
    Langtry HD; Spencer CM
    Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertension.
    Bajcetic M; Benndorf RA; Appel D; Schwedhelm E; Schulze F; Riekhof D; Maas R; Böger RH
    J Clin Pharmacol; 2007 Mar; 47(3):295-304. PubMed ID: 17322141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nisoldipine CC: clinical experience in hypertension.
    Langan J; Rodríguez-Mañas L; Sareli P; Heinig R
    Cardiology; 1997; 88 Suppl 1():56-62; discussion 63-5. PubMed ID: 9118169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of age and liver disease on the pharmacokinetics of the calcium antagonist, nisoldipine.
    Davidsson GK; Edwards JS; Davidson C
    Curr Med Res Opin; 1995; 13(5):285-97. PubMed ID: 7555038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of once daily versus twice daily nisoldipine as monotherapy in patients over 65 years of age.
    Davidsson GK; Smithard DJ; Edwards JS; Davidson C
    Clin Trials Metaanal; 1994 Oct; 29(2-3):103-11. PubMed ID: 10150222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of once daily and twice daily nisoldipine as monotherapy in essential hypertension.
    Davidsson GK; Edwards JS; Davidson C
    Control Clin Trials; 1996 Apr; 17(2):117-22. PubMed ID: 8860064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.
    Hamilton SF; Houle LM; Thadani U
    Heart Dis; 1999; 1(5):279-88. PubMed ID: 11720635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of nisoldipine coat core.
    Zannad F
    Am J Cardiol; 1995 Apr; 75(13):41E-45E. PubMed ID: 7726124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nisoldipine coat-core and heart rate response during treatment of hypertension.
    Zannad F
    Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.
    White WB; Mansoor GA; Pickering TG; Vidt DG; Hutchinson HG; Johnson RB; Noveck R
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):806-14. PubMed ID: 10480474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monotherapy with the calcium channel antagonist nisoldipine for systemic hypertension and comparison with diuretic drugs.
    Daniels AR; Opie LH
    Am J Cardiol; 1987 Sep; 60(8):703-7. PubMed ID: 3661439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.